Innate Pharma 2021 Financial Calendar
MARSEILLE, France, Dec. 02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
News
Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers
Basel, 2 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the…
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome…
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Offering
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or…
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein…
Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint
OV101 program in Angelman syndrome to pause pending full analysis of NEPTUNE trial and discussions…
Allena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Leading Independent Proxy Firms ISS and Glass Lewis Recommend Ocugen Stockholders Vote “FOR” Reverse Stock Split and Authorized Shares Amendment Proposals
MALVERN, Pa., Dec. 01, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…